| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdelhamid H. Elgazzar. Orthopedic Nuclear Medicine, 3rd edition. Springer Nature Switzerland AG 2024, ISBN 978-3-031-51931-4
|
Mansi, Luigi
|
|
|
52 |
6 |
p. 2245-2246
|
artikel
|
| 2 |
An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma
|
Suzuki, Hiroyuki
|
|
|
52 |
6 |
p. 2107-2117
|
artikel
|
| 3 |
Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma
|
Zhu, Dongling
|
|
|
52 |
6 |
p. 2132-2144
|
artikel
|
| 4 |
Beyond FAP: ANTXR1 as a novel target for PET imaging and radio-ligand therapy in immuno-oncology?
|
Seban, Romain-David
|
|
|
52 |
6 |
p. 1948-1950
|
artikel
|
| 5 |
Bilateral intense [68 Ga]Ga-PSMA‑11 uptake in cyproterone acetate induced gynecomastia
|
Bodart, Fiona
|
|
|
52 |
6 |
p. 1937-1938
|
artikel
|
| 6 |
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
|
Waibel, Philipp Moritz Adrian
|
|
|
52 |
6 |
p. 2023-2033
|
artikel
|
| 7 |
Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive glioma
|
Ahrari, Shamimeh
|
|
|
52 |
6 |
p. 1989-2001
|
artikel
|
| 8 |
Correction to: Feasibility of PET‑enabled dual‑energy CT imaging: First physical phantom and initial patient study results
|
Zhu, Yansong
|
|
|
52 |
6 |
p. 2239-2243
|
artikel
|
| 9 |
Correction to: Preclinical evaluation of 64Cu/177Lu‑labelled anti‑CD30 monoclonal antibody for theranostics in CD30‑positive lymphoma
|
Yang, Xu
|
|
|
52 |
6 |
p. 2244
|
artikel
|
| 10 |
Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET
|
Boccalini, Cecilia
|
|
|
52 |
6 |
p. 1958-1969
|
artikel
|
| 11 |
Exploring the role of multimodal [18F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer
|
Miao, Cunke
|
|
|
52 |
6 |
p. 2087-2095
|
artikel
|
| 12 |
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma
|
Lin, En
|
|
|
52 |
6 |
p. 2157-2170
|
artikel
|
| 13 |
First real-world clinical experience with [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria
|
Ling, Sui wai
|
|
|
52 |
6 |
p. 2034-2040
|
artikel
|
| 14 |
Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation
|
Holzgreve, Adrien
|
|
|
52 |
6 |
p. 1939-1941
|
artikel
|
| 15 |
[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients
|
Bauckneht, Matteo
|
|
|
52 |
6 |
p. 2076-2086
|
artikel
|
| 16 |
[18F]RCCB6 immunoPET/CT detects primary clear cell renal cell carcinoma
|
Wu, Shuo
|
|
|
52 |
6 |
p. 1944-1945
|
artikel
|
| 17 |
[68Ga]Ga‑FAPI PET/CT in the evaluation of Langerhans cell histiocytosis: comparison with [18F]FDG PET/CT
|
Zhang, Wenjie
|
|
|
52 |
6 |
p. 2187-2197
|
artikel
|
| 18 |
GLUT1 as a generic biomarker enables near-infrared fluorescence molecular imaging guided precise intraoperative tumor detection in breast cancer
|
Qiu, Si-Qi
|
|
|
52 |
6 |
p. 2171-2186
|
artikel
|
| 19 |
Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson’s disease
|
Silva-Rodríguez, Jesús
|
|
|
52 |
6 |
p. 2002-2014
|
artikel
|
| 20 |
Influence of diabetes mellitus on metabolic networks in lung cancer patients: an analysis using dynamic total-body PET/CT imaging
|
Sun, Lubing
|
|
|
52 |
6 |
p. 2145-2156
|
artikel
|
| 21 |
Letter to the editor about 360 CZT bone imaging
|
Graham, Richard
|
|
|
52 |
6 |
p. 1946-1947
|
artikel
|
| 22 |
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
|
Wenzel, Mike
|
|
|
52 |
6 |
p. 2015-2022
|
artikel
|
| 23 |
Moganshan international consensus on further strengthening global scientific collaboration in the field of molecular imaging
|
Tian, Mei
|
|
|
52 |
6 |
p. 1951-1954
|
artikel
|
| 24 |
Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy
|
Van Leeuwen, Fijs W.B.
|
|
|
52 |
6 |
p. 1955-1957
|
artikel
|
| 25 |
PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis
|
Zhang, Jucheng
|
|
|
52 |
6 |
p. 2212-2224
|
artikel
|
| 26 |
Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors
|
Jeong, Hyehyun
|
|
|
52 |
6 |
p. 2096-2106
|
artikel
|
| 27 |
Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer
|
Karimzadeh, Amir
|
|
|
52 |
6 |
p. 2041-2050
|
artikel
|
| 28 |
PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms
|
Ma, Qiaoke
|
|
|
52 |
6 |
p. 2063-2075
|
artikel
|
| 29 |
The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models
|
Liu, Luoxia
|
|
|
52 |
6 |
p. 2198-2211
|
artikel
|
| 30 |
The true negative [⁶⁸Ga]Ga-Trivehexin PET/CT in Solid Pseudopapillary Neoplasm of pancreas, mimicking pancreatic adenocarcinoma in [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI scans
|
Novruzov, Fuad
|
|
|
52 |
6 |
p. 1942-1943
|
artikel
|
| 31 |
Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy
|
Li, Rong
|
|
|
52 |
6 |
p. 1970-1988
|
artikel
|
| 32 |
Trends in nanobody radiotheranostics
|
Long, Xingru
|
|
|
52 |
6 |
p. 2225-2238
|
artikel
|
| 33 |
Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy
|
Zhang, Yafei
|
|
|
52 |
6 |
p. 2118-2131
|
artikel
|
| 34 |
Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy
|
Li, Yujia
|
|
|
52 |
6 |
p. 2051-2062
|
artikel
|
Tijdschrift beschrijving